Skip to main content

Table 3 Percentage difference in the absorbed dose calculations for different cut-offs using the tVOI method. Data are presented as median (min; max)

From: Method dependence, observer variability and kidney volumes in radiation dosimetry of 177Lu-DOTATATE therapy in patients with neuroendocrine tumours

 

50 %

60 %

70 %

Right kidney

42 %

0.9 (−0.6; 2.7)

−0.8 (−3.4; 1.9)

−2.8 (−5.8; 2.2)

50 %

 

−1.7 (−2.9; −0.5)

−3.7 (−6.5; −0.5)

60 %

  

−2.1 (−3.9; 0.3)

Left kidney

42 %

1.0 (−0.1; 2.0)

−0.4 (−2.4; 2.0)

−2.2 (−6.5; 1.5)

50 %

 

−1.4 (−2.7; 0.0)

−3.2 (−6.8; −0.5)

60 %

  

−1.9 (−4.2; −0.5)

Spleen

42 %

−1.0 (−0.7; 2.4)

−0.2 (−3.1; 3.0)

−1.4 (−5.4; 2.0)

50 %

 

−1.2 (−3.1; 0.5)

−2.4 (−4.8; 0.0)

60 %

  

−1.3 (−2.7; −0.1)